IndraLab

Statements

Rifaximin inhibits MYD88. 1 / 1

| 1

reach

"Rifaximin at 0.1, 1.0, and 10 muM inhibited TLR4 expression (-33, -50, and -75%) and reduced MyD88 (-29, -60, and -81%) and TAK1 expression (-37, -63, and -79%) in a concentration dependent manner, when compared with the TcdA group."

27242527

INDRA sources:

Colored badges next to statement headings correspond to evidence counts from knowledge sources, as shown below. Badges to the left of the | separator correspond to curated knowledge base sources, and badges to the right of it correspond to machine reading systems.

IndraLab

Statements

Rifaximin inhibits MYD88. 1 / 1

INDRA sources:

Databases

Reading